Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: A single-institution experience with 132 consecutive patients

S. M. Stemmer, I. Hardan, H. Raz, A. K. Adamou, M. Inbar, M. Gottfried, Y. Merrick, Y. Cohen, A. Sulkes, N. Ben-Baruch, R. P. Pfeffer, H. J. Brenner, S. Rizel

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Adjuvant treatment of high-risk stage II breast cancer with doxorubicin followed by high-dose chemotherapy and autologous stem-cell transplantation: A single-institution experience with 132 consecutive patients'. Together they form a unique fingerprint.

Medicine & Life Sciences